Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

EClinicalMedicine·2026
Same author

VGLL-fused intraparenchymal schwannoma with EWSR1::VGLL1 fusion: integrated clinicopathological and molecular characterization.

Acta neuropathologica communications·2026
Same author

Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study.

Translational lung cancer research·2026
Same author

TANC1::HTRA1 and KPNA4::WWTR1 fusions in non-vestibular intracranial schwannomas.

Acta neuropathologica·2026
Same author

Efficacy and safety of multimodality therapy stratified by resection rate and molecular markers in children and adolescents with ependymoma: JCCG EPN23 protocol.

Japanese journal of clinical oncology·2026
Same author

Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.

The Lancet. Child & adolescent health·2026
Same journal

[Current State and Challenges of Digital Health in Japan].

No shinkei geka. Neurological surgery·2026
Same journal

[Emergent Surgery for Brain Tumors].

No shinkei geka. Neurological surgery·2026
Same journal

[Concepts of Cerebrospinal Fluid Management Based on a Paradigm Shift in CSF Dynamics:From the Third Circulation to the Glymphatic System and Meningeal Lymphatic Drainage].

No shinkei geka. Neurological surgery·2026
Same journal

[Management of Severe Traumatic Brain Injury].

No shinkei geka. Neurological surgery·2026
Same journal

[Management of Cerebral Vasospasm in Subarachnoid Hemorrhage].

No shinkei geka. Neurological surgery·2026
Same journal

[Perioperative Management of Spine and Spinal Cord Surgery].

No shinkei geka. Neurological surgery·2026
See all related articles

Related Experiment Video

Updated: Oct 3, 2025

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.1K

[Pediatric Hemispheric Glioma].

Yoshiko Nakano1, Koichi Ichimura, Hiroaki Sakamoto

  • 1Department of Pediatrics, the University of Tokyo Hospital.

No Shinkei Geka. Neurological Surgery
|February 16, 2022
PubMed
Summary
This summary is machine-generated.

Pediatric hemispheric gliomas often have targetable genetic changes. Precision medicine, including gene panel testing, is advancing treatment for these pediatric brain tumors in Japan.

More Related Videos

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.6K
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

546

Related Experiment Videos

Last Updated: Oct 3, 2025

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.1K
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.6K
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

546

Area of Science:

  • Neuro-oncology
  • Genetics
  • Pediatric oncology

Background:

  • Pediatric hemispheric gliomas constitute a significant portion of pediatric brain tumors.
  • These tumors can harbor specific genetic abnormalities with therapeutic implications.

Purpose of the Study:

  • To review the genetic profiles of pediatric hemispheric gliomas.
  • To discuss the current landscape of precision medicine for pediatric glioma patients in Japan.

Main Methods:

  • Review of genetic profiles in pediatric hemispheric gliomas.
  • Analysis of current precision medicine approaches and challenges in Japan.

Main Results:

  • Identified key genetic alterations (e.g., BRAF V600E, H3.3 G34R/V, FGFR1, MYB/MYBL1, NTRK/ALK/ROS1/MET fusions).
  • Demonstrated efficacy of targeted agents (BRAF, MEK, NTRK inhibitors) and checkpoint inhibitors for specific glioma types.
  • Highlighted the benefit of cancer gene panel testing since its insurance approval in Japan.

Conclusions:

  • Pediatric hemispheric gliomas possess actionable genetic targets.
  • Precision medicine, supported by gene panel testing, offers promising therapeutic strategies for pediatric glioma patients in Japan.
  • Further efforts are needed to fully integrate molecular insights into clinical practice.